NALOXONE HYDROCHLORIDE INJECTION

The Defense Logistics Agency awarded a firm-fixed-price contract to DMS PHARMACEUTICAL GROUP INC with CAGE code 1UNB0 for the delivery of one unit of NALOXONE HYDROCHLORIDE INJECTION, identified by NSN 6505016271884 and NDC 76329-1469-01, at a total price of $149.88. The award was issued on July 16, 2026, under the parent delivery order SPE2DX25D9822, with delivery required to be made by the same date to Electric Boat Corporation at 25 Norwich Westerly Road, North Stonington, CT 06359. The contract specifies FOB Destination terms, meaning the contractor assumes all costs and risks of loss until physical delivery at the destination, where inspection and acceptance occur. Shipping is mandated to occur via the fastest traceable means with explicit prohibition of parcel post, and the item is to be identified with the DD Form N2716461902J30 and associated CLIN and CAGE identifiers. No specific packaging, labeling, or MIL-STD requirements are detailed, though traceability and proper identification are implied. The contract includes no options, quantity variance, or additional line items, with pricing fixed and non-negotiable. The award appears to stem from a simplified acquisition process, given the low value and single-item nature, though no explicit evaluation factors or solicitation criteria are documented in the available materials. While the contractor’s CAGE code is confirmed, no socioeconomic status, size certification, or affirmative representations are disclosed. Payment terms are not explicitly defined beyond the FOB designation, and no contracting officer, COR, COTR, or invoice submission instructions are provided. The contract is executed without reference to FAR clauses, special requirements, or formal attachments, suggesting it is a minimalistic, direct delivery award governed primarily by the line-item specifications and logistical directives.